Jefferies resumes coverage on Rentokil stock with Buy rating, cites US momentum
PositiveFinancial Markets

Jefferies has resumed coverage on Rentokil's stock with a Buy rating, highlighting strong momentum in the US market. This is significant as it reflects confidence in Rentokil's growth potential and could attract more investors, boosting the company's stock performance.
— Curated by the World Pulse Now AI Editorial System